5-(3-(2-((4'-(cyclohexylmethoxy)-[1,1'-biphenyl]-4-yl)methyl)-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl)phenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide

Catalog No. :
ACIGGK938
CAS No. :
945836-48-6
Molecular Formula :
C37H34Cl2N4O4S
Molecular Weight :
701.68

IUPAC Name:5-(3-(2-((4'-(cyclohexylmethoxy)-[1,1'-biphenyl]-4-yl)methyl)-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl)phenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide

5-(3-(2-((4'-(cyclohexylmethoxy)-[1,1'-biphenyl]-4-yl)methyl)-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl)phenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(3-(2-((4'-(cyclohexylmethoxy)-[1,1'-biphenyl]-4-yl)methyl)-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl)phenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
IUPAC Name5-(3-(2-((4'-(cyclohexylmethoxy)-[1,1'-biphenyl]-4-yl)methyl)-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl)phenyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
Molecular FormulaC37H34Cl2N4O4S
Molecular Weight701.68
SMILESO=C1CN(C2=CC=CC(N3C=C(C4=C(Cl)C=C(Cl)C=C4)N=C3CC3=CC=C(C4=CC=C(OCC5CCCCC5)C=C4)C=C3)=C2)S(=O)(=O)N1
InChI KeyCLICTJKGRVHEPA-UHFFFAOYSA-N
CAS No.945836-48-6

Synthetic Route by SureRoute

1. ACIGGK938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIGGK938 route product structure diagram
    ACIGGK938945836-48-6
Inquiry

2. ACIGGK938 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPQWS459 route compound structure diagram
    ACPQWS459100-49-2 In Stock
  4. Then
  5. ACIGGK938 route product structure diagram
    ACIGGK938945836-48-6
Inquiry

Comments (0)